celecoxib
Selected indexed studies
- Celecoxib for the treatment of musculoskeletal arthritis. (Expert Opin Pharmacother, 2019) [PMID:31339385]
- Celecoxib in Cancer Therapy and Prevention - Review. (Curr Drug Targets, 2019) [PMID:30073924]
- Celecoxib for the treatment of atherosclerosis. (Expert Opin Investig Drugs, 2016) [PMID:26940257]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Celecoxib for the treatment of musculoskeletal arthritis. (2019) pubmed
- Celecoxib in Cancer Therapy and Prevention - Review. (2019) pubmed
- Celecoxib for the treatment of atherosclerosis. (2016) pubmed
- Celecoxib for rheumatoid arthritis. (2017) pubmed
- Celecoxib-induced drug fever: A rare case report and literature review. (2022) pubmed
- Celecoxib safety revisited. (2016) pubmed
- Celecoxib for Stage III Colon Cancer. (2021) pubmed
- Celecoxib for osteoarthritis. (2019) pubmed
- Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3. (2024) pubmed
- Effect of celecoxib plus standard chemotherapy on cancer prognosis: A systematic review and meta-analysis. (2023) pubmed